Literature DB >> 19067777

Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal.

Christa Buechler1, Andreas Schäffler, Monika Johann, Markus Neumeier, Philip Köhl, Thomas Weiss, Norbert Wodarz, Paul Kiefer, Claus Hellerbrand.   

Abstract

BACKGROUND: Adiponectin is a circulating protein with hepatoprotective effects. AIMS: To study the relationship of excessive alcohol consumption and serum adiponectin levels (SAL). PATIENTS AND METHODS: The SAL were determined in (i) heavy drinkers without advanced liver damage during the course of alcohol withdrawal, (ii) patients with chronic hepatitis C virus (HCV) infection, (iii) patients with alcohol-associated cirrhosis, and (iv) healthy volunteers that consumed excessive amounts of alcohol for only a short period of time. Further, primary human hepatocytes (PHH) and adipocytes were incubated in vitro with alcohol or serum of patients.
RESULTS: Patients with chronic alcohol consumption had significantly higher SAL than HCV-patients with comparable degrees of liver damage. In alcoholics, but not in HCV patients, SAL positively correlated with serum levels of aminotransferases. Further, SAL correlated with the amount of alcohol consumption but declined during the course of alcohol abstinence. After short-term excessive alcohol consumption SAL were not elevated in healthy individuals. Adiponectin mRNA was detectable in adipocytes but not in hepatocytes, and alcohol failed to induce adiponectin in both cell types. In contrast, serum of active drinkers induced adiponectin expression in adipocytes while serum from the same individuals collected after alcohol withdrawal had no effect.
CONCLUSIONS: Alcohol exhibits a specific effect on SAL that is dose and time dependent, and correlates with the degree of hepatic damage. Alcohol does not seem to affect adiponectin expression directly in adipocytes but potentially via mediators systemically released as a result of the chronic alcohol intake.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19067777     DOI: 10.1111/j.1440-1746.2008.05693.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  17 in total

1.  Cognitive mediators and disparities in the relation between teen depressiveness and smoking.

Authors:  Ritesh Mistry; Giridhara R Babu; Tanmay Mahapatra; William J McCarthy
Journal:  Drug Alcohol Depend       Date:  2014-03-30       Impact factor: 4.492

Review 2.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

3.  Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis.

Authors:  Maria Kalafateli; Christos Triantos; Emmanuel Tsochatzis; Marina Michalaki; Efstratios Koutroumpakis; Konstantinos Thomopoulos; Venetsanea Kyriazopoulou; Eleni Jelastopulu; Andrew Burroughs; Chryssoula Lambropoulou-Karatza; Vasiliki Nikolopoulou
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

4.  Association of variants on ADIPOQ and AdipoR1 and the prognosis of gastric cancer patients after gastrectomy treatment.

Authors:  Xuming Wu; Peizhan Chen; Yiyi Ou; Jibin Liu; Chenglin Li; Hui Wang; Fulin Qiang
Journal:  Mol Biol Rep       Date:  2014-10-01       Impact factor: 2.316

Review 5.  Endocrine Adiponectin-FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury.

Authors:  Min You; Zhou Zhou; Michael Daniels; Alvin Jogasuria
Journal:  Gene Expr       Date:  2017-11-02

Review 6.  Adiponectin in inflammatory and immune-mediated diseases.

Authors:  Giamila Fantuzzi
Journal:  Cytokine       Date:  2013-07-11       Impact factor: 3.861

Review 7.  Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis.

Authors:  Jan Petrasek; Timea Csak; Michal Ganz; Gyongyi Szabo
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

8.  Leptin deficiency contributes to the pathogenesis of alcoholic fatty liver disease in mice.

Authors:  Xiaobing Tan; Xiuhua Sun; Qiong Li; Yantao Zhao; Wei Zhong; Xinguo Sun; Wei Jia; Craig J McClain; Zhanxiang Zhou
Journal:  Am J Pathol       Date:  2012-07-27       Impact factor: 4.307

9.  Genome-wide survival analysis of age at onset of alcohol dependence in extended high-risk COGA families.

Authors:  Manav Kapoor; Jen-Chyong Wang; Leah Wetherill; Nhung Le; Sarah Bertelsen; Anthony L Hinrichs; John Budde; Arpana Agrawal; Laura Almasy; Kathleen Bucholz; Danielle M Dick; Oscar Harari; Xuei Xiaoling; Victor Hesselbrock; John Kramer; John I Nurnberger; John Rice; Marc Schuckit; Jay Tischfield; Bernice Porjesz; Howard J Edenberg; Laura Bierut; Tatiana Foroud; Alison Goate
Journal:  Drug Alcohol Depend       Date:  2014-06-11       Impact factor: 4.492

10.  Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.

Authors:  Jason M Correnti; Egle Juskeviciute; Aditi Swarup; Jan B Hoek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.